Оценка влияния гриппозной инфекции и иммунизации живой реассортантной гриппозной вакциной на возникновение и течение IgE-опосредованных аллергических реакций организма
Диссертация
Альтернативой парентеральной ИГВ является живая холодоадаптированная реассортантная интраназальная вакцина (ЖГВ), разработанная академиком А. А. Смородинцевым и проф. Г. И. Александровой. Недавно подобная, но не идентичная вакцина лицензирована и в США. За более чем двадцатилетний период практического применения ЖГВ уровень клинических аллергических реакций у привитых людей никогда не превышал… Читать ещё >
Список литературы
- Александрова Г. И., Климов А. И. Живая вакцина против гриппа. СПб: Наука, 1994.-151 с.
- Баранцева И.Б. Возрастные особенности развития иммунного ответа людей на живую и инактивированную гриппозные вакцины: Автореф. дис. на соиск. уч. ст. канд. биол. наук. СПб., 2003. — 22 с.
- Баранцева И.Б., Найхин А. Н., Донина С. А. и др. Гуморальный и локальный иммунный ответ на гриппозные вакцины у пожилых и молодых людей // Вопросы вирусологии. 2003. — № 2. — С. 32 — 36.
- Бронхиальная астма. Глобальная стратегия. Совместный доклад Национального института Сердце, Легкие, Кровь и Всемирной Организации Здравоохранения // Пульмонология. 1996 (Приложение). — 166 с.
- Волкова О.В., Елецкий Ю. К. Основы гистологии с гистологической техникой. М.: Медицина, 1982. — 304 с.
- Государственные испытания и регистрация новых медицинских иммунобиологических препаратов: Санитарные правила. М.: Информационно-издательский центр Минздрава России, 1998. — 127 с.
- Дешева Ю.А. Разработка оптимальной схемы иммунизации против гриппа лиц пожилого возраста: Автореф. дис. на соиск. уч. ст. канд. мед. наук. СПб., 1998. — 21 с.
- Донина СА., Найхин А. Н., Петухова Г. Д. и др. Системный гуморальный и клеточный иммунный ответ при экспериментальной гриппозной инфекции и вакцинации // Медицинская иммунология. -2006.-Том 8. № 1. — С. 31 — 36.
- Западнюк И.П., Западнюк В. И., Захария Е. А. и др. Лабораторные животные. Разведение, содержание, использование в эксперименте. -Киев.: Вища школа, 1983. 383 с.
- Ю.Зурочка А. В., Долгушин И. И., Квятковская С. В. и др. Латентная сенсибилизация. Челябинск: Изд-во «Челябинская государственная медицинская академия», 2005. — 181 с.
- П.Йегер Л. Клиническая иммунология и аллергология: Пер. с нем.: В 3 т. / Под ред. Л. Йегера. М.: Медицина, 1986. — Т. 2. — 512 с.
- Карпухин Г. И. Грипп. СПб.: Гиппократ, 2001. — 359 с.
- Медуницин Н.В. Вакцинология. М.: Триада-Х, 2004. — 448 с.
- Методические указания к работе опорных баз Всесоюзного центра по гриппу и ОРЗ. Л, 1986. — С. 40−42.
- Найхин А.Н., Руденко Л.Г, Арден Н. и др. Формирование гуморального и секреторного иммунитета у лиц пожилого возраста при различных схемах иммунизации гриппозными вакцинами // Вопросы вирусологии. 1998. — № 1. — С. 20−24.
- Найхин А.Н., Руденко Л.Г, Арден Н. и др. Иммунный ответ лиц пожилого возраста в зависимости от числа ежегодных сезонных иммунизаций живой и инактивированной гриппозными вакцинами // Вопросы вирусологии. 1998. — № 3. — С. 130−134.
- Найхин А. Н, Рекстин А. Р., Баранцева И. Б. и др. Иммунный ответ на Р живую гриппозную вакцину // Вестник РАМН. 2002. — № 12. — С.2428.
- Руденко Л. Г, Шварцман Я. С, Исполатова А. В. и др. Основные характеристики живой гриппозной вакцины для детей из штаммов вирусов гриппа A (H1N1) и A (H3N2) при раздельном и совместном их применении // Вопросы вирусологии 1989. — № 1. — С. 29 — 34.
- Смородинцев А.А. Грипп и его профилактика. Л.: Медицина, 1984. -384 с.
- Тотолян А. А. Иммуноглобулин Е. Структура, продукция, биологические эффекты и диагностическое использование // Аллергология. 1998. — № 2. — С. 4 — 7.
- Федосеев Г. Б. Бронхиальная астма. СПб.: Медицинское информационное агентство, 1996. — 464 с.
- Федосеев Г. Б. Общая аллергология: В 2 т. СПб.: Нормед-Издат, 2001. -816 с.
- Хаитов М.Р. Роль респираторных вирусов в патогенезе бронхиальной астмы // Иммунология. 2003. — № 1. — С. 58 — 65.
- Хаитов P.M., Jlycc Л.В., Арипова Т. У. и др. Распространенность симптомов бронхиальной астмы, аллергического ринита и аллергодерматозов у детей по критериям ISAAC // Аллергия, астма и клин, иммунол. 1998. — № 9. — С. 58 — 69.
- Хаитов P.M., Пинегин Б. В. Оценка иммунного статуса в норме и патологии // Иммунология. 2001. — № 4. — С. 4 — 6.
- Хаитов P.M., Пинегин Б. В., Истамов Х. И. Экологическая иммунология. -М.: ВНИРО, 1995.-219 с.
- Ярилин А.А. Основы иммунологии. М.: Медицина, 1999. — 608 с.
- Abadoglu О., Mungan D., Pasaoglu G. et al. Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations // J. Asthma. 2004. — Vol. 41. — P. 279 — 283.
- Aiba H., Mochizuki M., Kimura M. et al. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy // Neurology. 2001. — Vol. 57. — P. 295 — 299.
- Allen J.E., Maizels R.M. Immunology of human helminth infection // Int. Arch. Allergy Immunol. 1996. — Vol. 109. — P. 3 — 10.
- Antonis A.F., Schrijver R.S., Daus F. et al. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis // J. Virol. 2003. — Vol. 77. — P. 12 067- 12 073.
- Asanuma H., Thompson A.H., Iwasaki T. et al. Isolation and characterization of mouse nasal-associated lymphoid tissue // J. Immunol. Methods. 1997. — Vol. 202. — P. 123 — 131.
- Atmar R.L., Guy E., Guntupalli K.K. et al. Respiratory tract viral infections inner-city asthmatic adults // Arch. Intern. Med. 1998. — Vol. 158. — P. 2453−2459.
- Azevedo A.M., Durigon E.L., Okasima V. et al. Detection of influenza, parainfluenza, adenovirus and respiratory syncytial virus during asthma attacks in children older than 2 years old // Allergol. Immunopathol. (Madr). -2003.-Vol. 31. P. 311 -317.
- Babiuk S., Skowronski D.M., De Serres G. et al. Aggregate content influences the Thl/Th2 immune response to influenza vaccine: Evidence from a mouse model // J. Med. Virol. 2004. — Vol. 72. — P. 138 — 142.
- Bardin P.G., Sanderson G., Robinson B.S. et al. Experimental rhinovirus infection in volunteers // Eur. Respir. J. 1996. — Vol. 9. — P. 2250 — 2255.
- Barends M., Boelen A., de Rond L. et al. Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice // Clin. Exp. Allergy. 2002. — Vol. 32. — P. 463 — 471.
- Barends M., de Rond L.G., Dormans J. et al. Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice // Clin. Exp. Allergy. 2004. — Vol. 34. — P. 488 — 496.
- Barends M., Van Oosten M., De Rond C.G. et al. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation // J. Infect. Dis. 2004. — Vol. 189. — P. 1866 — 1872.
- Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Thl/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy—a review // Virus Genes. 2006. — Vol. 33. — P. 235 — 252.
- Bell T.D., Leffert F., Mcintosh K. Monovalent influenza A/New Jersey/76 virus vaccines in asthmatic children: pulmonary function and skin tests for allergy // J. Infect. Dis. 1977. — Vol. 136. — P. S612 — S615.
- Boyd M., Clezy K., Lindley R. et al. Pandemic influenza: clinical issues // Med. J. Aust. 2006. — Vol. 185. — P. S44 — S47.
- Bueving H.J. Is influenza vaccination in asthmatic children helpful? // Clin. Exp. Allergy. 2006. — Vol. 36. — P. 21 — 25.
- Bueving H.J., Bernsen R.M., de Jongste J.C. et al. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial // Am. J. Respir. Crit. Care Med. 2004. — Vol. 169. — P. 488 — 493.
- Сакшап I., Rohr J., Schutz R.M. et al. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly // Mech. Aging Dev. 1996. — Vol. 87. -P. 197−209.
- Calder P.C., Krauss-Etschmann S., de Jong E.C. et al. Early nutrition and immunity progress and perspectives // Br. J. Nutr. — 2006. — Vol. 96. — P. 774 — 790.
- Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) // MMWR. 2005. — Vol. 54. — P. 1 — 40.
- Chiu W.J., Kuo M.L., Chen L.C. et al. Evaluation of clinical and immunological effects of inactivated influenza vaccine in children with asthma // Pediatr. Allergy Immunol. 2003. — Vol. 14. — P. 429 — 436.
- Christy С., Aligne C.A., Auinger P. et al. Effectiveness of influenza vaccine for the prevention of asthma exacerbations // Arch. Dis. Child. 2004. -Vol. 89.-P. 734−735.
- Clements M.L. Influenza vaccines // Bio Technology. 1992. — Vol. 20. — P. 129- 150.
- Clementsen P., Hannoun C., Norn S. Influenza A virus enhances allergic histamine release. Effect of neuraminidase // Allegy. 1989. — Vol. 44. — P. 33 -38.
- Coyle A.J., Bertrand C., Tsuyuki S. et al. IL-4 differentiates naive CD8+ T cells to a «Th2-like» phenotype: a link between viral infections and bronchial asthma // Ann. N. Y. Acad. Sci. 1996. — Vol. 796. — P. 97 — 103.
- Coyle A.J., Erard F., Bertrand C. et al. Virus-specific CD8+ cells switch to interleukin 5 production and induce airway eosinophilia // J. Exp. Med. -1995.-Vol. 181.-P. 1229- 1233.
- Davies R., Pepys J. Egg allergy, influenza vaccine, and immunoglobulin E antibody // J. Allergy Clin. Immunol. 1976. — Vol. 57. — P. 373 — 383.
- Delespesse G., De Maubeuge J., Kennes B. et al. IgE mediated hypersensitivity in ageing // Clin. Allergy. 1977. — Vol. 7. — P. 155 — 160.
- De Serres G., Toth E., Menard S. et al. Oculorespiratory syndrome after influenza vaccination: trends over four influenza seasons // Vaccine. -2005. Vol. 23. — P. 3726 — 3732.
- Dudas R.A., Karron R.A. Respiratory syncytial virus vaccines // Clin. Microbiol. Rev. 1998. — Vol. 11. — P. 430 — 439.
- Etchart N., Baaten В., Andersen S.R. et al. Intranasal immunization with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge. // Eur. J. Immunol. 2006. — Vol. 36.-P. 1136−1144.
- Fairchok M.P., Trementozzi D.P., Carter P. S. et al. Effect of prednisone response to influenza vims vaccine in asthmatic children // Arch. Pediatr. Adolesc. Med.-1998.-Vol. 152.-P. 1191−1195.
- Falsey A.R., Henessey P.A., Formica M.A. et al. Respiratory syncytial virus infection in elderly and high-risk adults // N. Engl. J. Med. 2005. — Vol. 352.-P. 1749- 1759.
- Falsey A.R., Walsh E.E. Respiratory syncytial virus infection in adults // Clin. Microbiol. Rev. 2000. — Vol. 13. — P. 371 — 384.
- Fleming D.M., Pannell R.S., Elliot A.J. et al. Respiratory illness associated with influenza and respiratory syncytial virus infection // Arch. Dis. Child. -2005.-Vol. 90.-P. 741 -746.
- Flurkey K., Stadecker M., Miller R.A. Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency // Eur. J. Immunol. 1992. — Vol. 22. — P. 931 — 935.
- France E.K., Glanz J.M., Xu S. et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study // Arch. Pediatr. Adolesc. Med.-2004.-Vol. 158.-P. 1031 1036.
- Frick O.L., German D.F., Mills J. Development of allergy in children. I. Association with virus infections // J. Allergy Clin. Immunol. 1979. — Vol. 63.-P. 228−241.
- Gentile D.A., Doyle W.J., Fireman P. et al. Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects // Ann. Allergy Asthma Immunol. 2001. -Vol. 87.-P. 496−500.
- Gentile D., Doyle W., Whiteside T. et al. Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection // Clin. Diagn. Lab. Immunol. 1998. — Vol. 5. — P. 604 — 608.
- Gentile D.A., Patel A., Ollila C. et al. Diminished IL-10 production in subjects with allergy after infection with influenza A virus // J. Allergy Clin. Immunol.- 1999.-Vol. 103.-P. 1045- 1048.
- Gern J.E., Calhoun W.J., Swenson C. et al. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects // Am. J. Respir. Crit. Care Med. 1997. — Vol. 155. — P. 1872- 1876.
- Gern J.E., Martin M.S., Anklam K.A. et al. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy // Pediatr. Allergy Immunol. 2002. — Vol. 13. — P. 386 — 393.
- Gern J.E., Vrtis R., Grindle K.A. et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection // Am. J. Respir. Crit. Care Med. 2000. Vol. 1622. — P. 226 — 231.
- Goodman M.J., Nordin J.D., Harper P. et al. The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age // Pediatrics. 2006. -Vol. 117.-P. 821 -826.
- Gudmundsson K.O., Thorsteinsson L., Gudmundsson S. et al. Immunoglobulin-secreting cells in cord blood: effects of Epstein-Barr virus and interleukin-4 // Scand. J. Immunol. 1999. Vol. 50. — P. 21 — 24.
- Hancock G.E., Heers K.M., Smith J.D. QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus // Viral. Immunol. 2000. — Vol. 13. — P. 503 -509.
- Hartmann A.L., Wuthrich В., Deflorin-Stolz R. et al. Atopy screening: prick multitest, total IgE or RAST? On the value of allergologic testing of the staff of an industrial bakery // Schweiz. Med. Wochenschr. 1985. — Vol. 115. — P. 466 — 475.
- Hodge L.M., Marinaro M., Jones H.P. et al. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization // Infect. Immun. 2001. — Vol. 69. -P. 2338−2338.
- Holt P.G.,. Clough J. B, Holt B.J. et al. Genetic «risk» for atopy is associated with delayed postnatal maturation of T-cell competence // Clin. Exp. Allergy. 1992. — Vol. 22. — P. 1093 — 1099.
- Holt P.G., Sly P.D. Interactions between respiratory tract infections and atopy in the aetiology of asthma // Eur. Respir. J. 2002. — Vol. 19. — P. 538 -545.
- Holt P.G., Vines J., Bilyk N. Effect of influenza virus infection on allergic sensitization to inhaled antigen in mice // Int. Arch. Allergy Appl. Immunol. 1988. — Vol. 86. — P. — 121 — 123.
- Hurst S.D., Seymour В., Muchamuel T. et al. Modulation of inhaled antigen-induced IgE tolerance by ongoing Th2 responses in the lung // J. Immunol. -2001.-Vol. 166.-P. 4922−4930.
- Kallas E.G., Gibbons D.C., Soucier H. et al. Detection of intracellular antigen-specific cytokines in human T cell populations // J. Infect. Dis. -1999.-Vol. 179.-P. 1124−1131.
- Kawada J, Kimura H, Ito Y. et al. Systemic cytokine responses in patients with influenza-associated encephalopathy // J. Infect. Dis. 2003. — Vol. 188.-P. 690−698.
- Khanna M, Kumar P, Chugh L. et al. Evaluation of influenza virus detection by direct enzyme immunoassay (EIA) and conventional methods in asthmatic patients // J. Commun. Dis. 2001. — Vol. 33. — P. 163 — 169.
- Kim H. W, Canchola J. G, Brandt C.D. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine // Am. J. Epidemiol. 1969. — Vol. 89. — P. 422 — 434.
- Kneyber M.C.J, Steyerberg E. W, de Groot R. et al. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review // Acta Paediatr. 2000. — Vol. 89. — P. 654 -660.
- Kocabas E, Yapicioglu H, Yildizdas D. et al. The prevalence of atopy in children with antibodies against hepatitis A virus and hepatitis В virus // Turk. J. Pediatr. 2006. — Vol. 48. — P. 189 — 196.
- Koonstra P. J, De Jong F, Veek L. et al. The Valdeyer ring equivalent in the rat // Acta Otolaryng. 1991. — Vol. 111. — P. 591 — 599.
- Kristjansson S, Bjarnarson S. P, Wennergren G. et al. Respiratory syncytial virus and other respiratory viruses during the first 3 month of life promote a local Th2-like response // J. Allergy Clin. Immunol. 2005. — Vol. 116. — P. 805−811.
- Lawrence G, Boyd I, Mclntyre P. et al. Annual report: Surveillance of adverse events following immunization in Australia, 2005 // Commun. Dis. Intell. 2006. — Vol. 30. — P. 319 — 333.
- Lebrec H, Sarlo K, Burleson G.R. Effect of influenza virus infection on ovalbumin-specific IgE responses to inhaled antigen in the rat // J. Toxicol. Environ. Health. 1996. — Vol. 27. — P. 619 — 630.
- Legg J. P, Hussain I. R, Warner J.A. et al. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis // Am. J. Respir. Crit. Care Med. 2003. — Vol. 168. — P. 633 — 639.
- Liu J, Wang S, Liu H. et al. The monitoring biomarker for immune function of lymphocytes in the elderly // Mech. Ageing Dev. 1997. — Vol. 94.-P. 177- 182.
- Margolis K. L, Nichol K. L, Poland G.A. et al. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial // JAMA. 1990. — Vol. 264. — P. 1139 — 1141.
- Marshall G.D. Internal and external environmental influences in allergic diseases // J. Am. Osteopath. Assoc. 2004. — Vol. 104. — P. SI — S6.
- Marsland B.J., Harris N.L., Camberis M. et al. Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells // Proc. Natl. Acad. Sci. USA. 2004. — Vol. — P. 6116 — 6121.
- Mbawuike I.N., Acuna C.L., Walz K.C. et al. Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12 // Mech. Ageing Dev. 1997. — Vol. 94. — P. 25 — 39.
- Message S.D., Johnston S.L. The immunology of virus infection in asthma // Eur. Respir. J.-2001.-Vol. 18.-P. 1013- 1025.
- Meyer K.C. Aging // Proc. Am. Thorac. Soc. 2005. — Vol. 2. — P. 433 -439.
- Minino A.M., Heron M.P., Smith B.L. Deaths: preliminary data for 2004 // Natl. Vital. Stat. Rep. 2006. — Vol. 54. — P. 1 — 49.
- Moran T.M., Isobe H., Fernandez-Sesma A. et al. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice // J. Virol. 1996. -Vol. 70.-P. 5230−5235.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays // J. Immunol. Methods. 1983.-Vol. 65.-P. 55−63.
- Nakayama Т., Onoda K. Vaccine adverse events reported in postmarketing study of the Kitasato Institute from 1994 to 2004 // Vaccine. -2006. Vol. 25. — P. 570 — 576.
- Nakazawa Т., Houjyo S., Dobashi K. et al. Influence of aging and sex on specific IgE antibody production // Intern Med. 1994. — Vol. 33. — P. 396 -401.
- Nichol K.L., Margolis K.L., Lind A. et al. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial // Arch. Intern. Med. 1996. — Vol. 156. — P. 1546 — 1550.
- Nicholson K.G., Nguyen-Van-Tam J.S., Ahmed A.H. et al. Randomized placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma // Lancet. 1998. — Vol. 35. — P. 326 -331.
- Oh S., Eichelberger M.C. Polarization of allogenic T-cell responses by influenza virus-infected dendritic cells // J. Virol. 2000. — Vol. 74. — P. 7738−7744.
- Openshaw P.J., Culley F.J., Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease // Vaccine. 2001. — Vol. 15 — P. 27 — 31.
- Openshaw P.J., Tregoning J.S. Immune responses and disease enhancement during respiratory syncytial virus infection // Clin. Microbiol. Rev.-2005.-Vol. 18.-P. 541 -555.
- Openshaw P.J., Yamaguchi Y., Tregoning J.S. Childhood infections, the developing immune system, and the origins of asthma // J. Allergy Clin. Immunol. 2004. — Vol. 114. — P. 1275 — 1277.
- Pala P., Bjarnason R., Sigurbergsson F. et al. Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy // Eur. Respir. J. 2002. — Vol. 20. — P. 376 — 382.
- Papadopoulos N.G., Bates P.J., Bardin P.G. et al. Rhinoviruses infect the lower airways // J. Infect. Dis. 2000. — Vol. 181. — P. 1875 — 1884.
- Park J.H., Shin B.C., Do B.H. et al. Serum IgE levels in Korean patients with human immunodeficiency virus infection // Korean J. Intern. Med. -2002.-Vol. 17.-P. 88−93.
- Peebles R.S. Jr., Hashimoto K., Collins R.D. et al. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges // J. Infect. Dis. 2001. — Vol. 184.-P. 1374- 1379.
- Piedra P.A., Cron S.G., Jewell A. et al. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis // Vaccine. 2003. — Vol. 21. — P. 2448 — 2460.
- Prescott S.L., Macaubas C., Smallacombe T. et al. Development of allergen-specific T-cell memory in atopic and normal children // Lancet. -1999.-Vol. 353.-P. 196−200.
- Rabatic S., Gagro A., Lokar-Kolbas R. et al. Increase in CD23+ В cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus // J. Infect. Dis. 1997. -Vol. 175.-P. 32−37.
- Rager K.J., Langland J.O., Jacobs B.L. et al. Activation of antiviral protein kinase leads to immunoglobulin E class switching in human В cells // J. Virol. 1998. — Vol. 72. — P. 1171 — 1176.
- Regner M., Culley F., Fontannaz P. et al. Safety and efficacy of immune complex-based antigen delivery systems for neonatal immunization against respiratory syncytial virus infection // Microbes Infect. 2004. — Vol. 6. — P. 666−675.
- Riedel F., Krause A., Slenczka W. et al. Parainfluenza-3-virus infection enhances allergic sensitization in the guinea-pig // Clin. Exp. Allergy. -1996.-Vol. 26.-P. 603−609.
- Roger P.M., Eberhartd P., Sola L. et al. Evaluation of a hospitalization unit opened during the winter influenza epidemic of 1999 2000 // Rev. Med. Interne. — 2001. — Vol. 22. — P. 433 — 439.
- Rudenko L.G., Arden N.H., Grigorieva E. et al. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents // Vaccine. 2000. -Vol. 19.-P. 308−318.
- Rudenko L.G., Lonskaya N.I., Klimov A.I. et, al. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 314-year-olds // Bull. World Health Organ. 1996. — Vol. 74. — P. 77 — 84.
- Rudenko L.G., Slepushkin A.N., Monto A.S. et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia // J. Infect. Dis. 1993. — Vol. 168.-P. 881 -887.
- Saarinen U.M., Juntunen K., Kajosaari M. et al. Serum immunoglobulin E in atopic and non-atopic children aged 6 months to 5 years. A follow-up study // Acta Paediatr. Scand. 1982. — Vol. 71. — P. 489 — 494.
- Sakamoto M., Ida S., Takishima T. Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice // J. Immunol. -1984.-Vol. 132.-P. 2614−2617.
- Sakata-Kaneko S., Wakatsuki Y., Matsunaga Y. et al. Altered Thl/Th2 commitment in human CD4+ T cells with ageing // Clin. Exp. Immunol. -2000.-Vol. 120.-P. 267−273.
- Sampalis J.S. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants // J. Pediatr. 2003. -Vol. 143.-P. S150-S156.
- Saxena R.K., Weissman D., Simpson J. et al. Murine model of BCG lung infection: dynamics of lymphocyte subpopulations in lung interstitium and tracheal lymph nodes // J. Biosci. 2002. — Vol. 27. — P. 143 — 153.
- Schauer U., Hoffjan S., Bittscheidt J. et al. RSV bronchiolitis and risk of wheeze and allergic sensitization in the first year of life // Eur. Respir. J. -2002. Vol. 20. — P. 1277 — 1283.
- Sener M., Gursel G., Turktas H. Effects of inactivated influenza virus vaccination on bronchial reactivity symptom scores and peak expiratory flow variability in patients with asthma // J. Asthma. 1999. — Vol. 36. — P. 165−169.
- Siegrist C.A. Neonatal and early life vaccinology // Vaccine. 2001. -Vol. 19.-P. 3331 -3346.
- Sigurs N., Bjarnason R., Sigurbergsson F. et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls // Pediatrics. 1995. -Vol. 95.-P. 500−505.
- Sigurs N., Bjarnason R., Sigurbergsson F. et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7 // Am. J. Respir. Crit. Care Med. 2000. — Vol. 161. — P. 1501 — 1507.
- Sigurs N., Gustafsson P.M., Bjarnason R. et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13 // Am. J. Respir. Crit. Care Med. 2005. — Vol. 171. — P. 137 — 141.
- Simecka J.W., Jackson R.J., Kiyono H. et al. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract // Infect. Immun. 2000. — Vol. 68. — P. 672 — 679.
- Skoner D.P., Doyle W.J., Tanner E.P. et al. Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects // Clin. Exp. Allergy. 1995. — Vol. 25. — P. 561 — 567.
- Skoner D.P., Gentile D.A., Patel A. et al. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus // J. Infect. Dis. 1999. — Vol. 180. — P. 10 — 14.
- Skowronski D. M, Strauss B, De Serres G. et al. Oculorespiratory syndrome: A new influenza vaccine-associated adverse event? // Clin. Infect. Dis. 2003. — Vol. 36. — P. 705 — 713.
- Smith S, Demicheli V., Di Pietrantonj C. et al. Vaccines for preventing influenza in healthy children // Cochrane Database Syst. Rev. 2006. — Vol.25. CD004879.
- Stein R. T, Sherrill D, Morgan W.J. et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years // Lancet. 1999. -Vol. 354.-P. 541 -545.
- Stenius-Aarniala B, Huttunen J. K, Pyhala R. et al. Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus // Chest. 1986. — Vol. 89. — P. 786 — 789.
- Strachan D.P. Hay fever, hygiene, and household size // B.M.J. 1989. -Vol. 299.-P. 1259- 1260.
- Sudowe S, Arps V, Vogel T. et al. The role of interleukin-4 in the regulation of sequential isotype switch from immunoglobulin G1 to immunoglobulin E antibody production // Scand. J. Immunol. 2000. -May.-Vol. 51.-P. 461 -471.
- Sung R. Y, Hui S. H, Wong C.K. et al. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants //Eur. J. Pediatr.-2001.-Vol. 160.-P. 117−122.
- Tamura S, Tanimoto T, Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines // Jpn. J. Infect. Dis. 2005. — Vol. 58. — P. 195 — 207.
- Tan W. C, Xiang X, Qiu D. et al. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease // Am. J. Med. 2003. — Vol. 115. -P. 272−277.
- Tang Y.W. Cytokine pattern is solely influenced by priming vaccine but immunity and disease by both priming and boosting vaccines in mice challenged with respiratory syncytial virus // Virus Res. 2004. — Vol. 99. -P. 81−87.
- Tanyeri H, Kucukay S, Dursun G. et al. OC11 Hyperimmunoglobulin E syndrome presenting with oral premalignant papillomas // Oral. Dis. 2006. Vol. 12.-P. 11−12.
- Tariq S. M, Matthews S. M, Stevens M. et al. Sensitization to Alternaria and Cladosporium by the age of 4 years // Clin. Exp. Allergy. 1996. — Vol.26.-P. 794−798.
- Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma // Chest. 1997. -Vol. 112.-P. 591 -596.
- Thompson W.W., Shay D.K., Weintraub E. et al. Mortality associated with influenza and respiratory syncytial virus in the United States // JAMA -2003. Vol. 289.-P. 179−186.
- Torres R., Picado C., de Mora F. Use of the mouse to unravel allergic asthma: a review of the pathogenesis of allergic asthma in mouse models and its similarity to the condition in humans // Arch. Bronconeumol. 2005. -Vol.41.-P. 141−152.
- Tsitoura D.C., Kim S., Dabbagh K. et al. Respiratory infection with influenza A virus interferes the induction of tolerance to aeroallergens // J. Immunol. 2000. — Vol. 165. — P. 3484 — 3491.
- Tumas D.B., Chan В., Werther W. et al. Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization // J. Allergy Clin. Immunol. 2001. — Vol. 107. — P. 1025 — 1033.
- Upham J.W., Holt P.G. Environment and development of atopy // Curr. Opin. Allergy Clin. Immunol. 2005. — Vol. 5. — P. 167 — 172
- Vaughan K., Rhodes G.H., Gershwin L.J. DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys // Vaccine. -2005. Vol. 23. — P. 2928 — 2942.
- Welliver R.C. Respiratory syncytial virus and other respiratory viruses // Pediatr. Infect. Dis. J. 2003. — Vol. 22. — P. 6 — 10.
- Welliver R.C., Sun M., Rinaldo D. et al. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis // J. Pediatr. 1986. — Vol. 109. — P. 776 — 780.
- Wills-Karp M., Luyimbazi J., Xu X. et al. Interleukin-13: central mediator of allergic asthma // Science. 1998. — Vol. 282. — P. 2258 — 2261.
- Yamamoto N., Suzuki S., Shirai A. et al. Dendritic cells are associated with augmentation of antigen sensitization by influenza A virus infection in mice // J. Immunol. 2000. — Vol. 30. — P. 316 — 326.
- Yamamoto N., Suzuki S., Suzuki Y. et al. Immune response induced by airway sensitization after influenza A virus infection depends on timing of antigen exposure in mice // J. Virol. 2001. — Vol. 75. — P. 499 — 505.
- Yamane N., Uemura H. Serological examination of IgE- and IgG-specific antibodies to egg protein during influenza virus immunization // Epidemiol. Infect. 1988. — Vol. 100. — P. 291 — 299.
- Yasuda H., Suzuki Т., Zayasu K. et al. Inflammatory and bronchospastic factors in asthma exacerbations caused by upper respiratory tract infections // Tohoku J. Exp. Med. 2005. — Vol. 207. — P. 109 — 118.
- Zhang Y., Wang Y., Gilmore X. et al. An aged mouse model for RSV infection and diminished CD8(+) CTL responses // Exp. Biol. Med. (Maywood). 2002. — Vol. 227. — P. 133 — 140.
- Zhao J., Takamura M., Yamaoka A. et al. Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood // Pediatr. Allergy Immunol. 2002. — Vol. 13. — P. 47 — 50.
- Zou Y., Xu J., Zhong N. Effect of respiratory syncytial virus infection on T-helper cytokines expression in Balb/c mice sensitized with ovalbumin // Zhonghua Jie He He Hu Xi Za Zhi. 2002. — Vol. 25. — P. 470 — 474.
- От всей души благодарю своего научного руководителя Анатолия Нойевича Найхина за неоценимую помощь и поддержку, оказанную в ходе выполнения работы.
- Выражаю искреннюю признательность всем сотрудникам отдела вирусологии ГУ НИИЭМ РАМН, особенно Светлане Александровне Дониной, Елене Петровне Григорьевой и Андрею Роальдовичу Рекстину за активное участие и помощь в освоении новых методик.
- Искренне благодарю ведущего научного сотрудника отдела биохимии ГУ НИИЭМ РАМН Петра Валерьевича Пигаревского за помощь в интерпретации патоморфологических данных.
- Выражаю глубокую признательность руководителю отдела вирусологии ГУ НИИЭМ РАМН Ларисе Георгиевне Руденко за предоставленную возможность обучения в аспирантуре, всестороннюю помощь и поддержку.